Ardea Biosciences (RDEA) Posts Q3 Loss of $0.13, Tops Views
More News related to RDEA
- Ardea Biosciences (RDEA) Posts Q3 Loss of $0.13, Tops Views
- Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results
- Ardea Biosciences to Present at Three Upcoming Investor Conferences
- Ardea Bio (RDEA) Results Positive in Phase IIa RDEA594 Study; Will Announce at ACR/ARHP Scientific Meeting
- Ardea Biosciences Announces Additional Positive Results from a Phase 2a Study of RDEA594 at the 2009 ACR/ARHP Annual Scientific Meeting
Ardea Biosciences, Inc. (NASDAQ: RDEA) reports Q3 EPS of $0.13, versus the analyst estimate of ($0.53). Revenue for the quarter was $ million, which compares to the estimate of $3.51 million.
Related Categories
EarningsStocks Mentioned
+0.91Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
